BioDiem Ltd - Strategic SWOT Analysis Review
- GDPH61751SA
- Pages: 25
- November 2018
- Region : Asia
- GlobalData
- Equity Research Report

- Details
- Table Of Content
- Licence Rights
- Section Purchase
- Products and Companies
Details
BioDiem Ltd-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-GlobalData's summarization of the company's business strategy.
- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
Highlights
BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company's product portfolio includes Live Attenuated Influenza Virus (LAIV) vaccine technology, used for production of seasonal and pandemic influenza vaccines and antimicrobial BDM-I for the treatment of serious human infections. BioDiem partners with other vaccine and infectious disease treatment companies through licensing its LAIV vaccine and other technologies. The LAIV is licensed to World Health Organisation as part of the Global Pandemic Influenza Action Plan. BioDiem is headquartered in South Melbourne, Victoria, Australia.
BioDiem Ltd Key Recent Developments
Mar 17,2017: BioDiem Announces its Half Year Results
Reasons to buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1-About the Company 5
BioDiem Ltd-Key Facts 5
BioDiem Ltd-Key Employees 6
BioDiem Ltd-Key Employee Biographies 7
BioDiem Ltd-Major Products and Services 8
BioDiem Ltd-History 9
BioDiem Ltd-Company Statement 11
BioDiem Ltd-Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2-Company Analysis 13
Company Overview 13
BioDiem Ltd-Business Description 14
BioDiem Ltd-Corporate Strategy 15
BioDiem Ltd-SWOT Analysis 16
SWOT Analysis-Overview 16
BioDiem Ltd-Strengths 16
BioDiem Ltd-Weaknesses 17
BioDiem Ltd-Opportunities 18
BioDiem Ltd-Threats 19
BioDiem Ltd-Key Competitors 20
Section 3-Company's Lifesciences Financial Deals and Alliances 21
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
BioDiem Ltd, Recent Deals Summary 23
Section 4-Company's Recent Developments 24
Mar 17, 2017: BioDiem Announces its Half Year Results 24
Section 5-Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List Of Figure
List of Figures
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 22
List Of Table
List of Tables
BioDiem Ltd, Key Facts 5
BioDiem Ltd, Key Employees 6
BioDiem Ltd, Key Employee Biographies 7
BioDiem Ltd, Major Products and Services 8
BioDiem Ltd, History 9
BioDiem Ltd, Subsidiaries 12
BioDiem Ltd, Key Competitors 20
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
BioDiem Ltd, Recent Deals Summary 23
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
Products and Companies
Products
BioDiem Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.
Companies
Therapix Biosciences Ltd
MedImmune LLC
Altimmune Inc
AdAlta Ltd
BioDiem Ltd-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-GlobalData's summarization of the company's business strategy.
- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
Highlights
BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company's product portfolio includes Live Attenuated Influenza Virus (LAIV) vaccine technology, used for production of seasonal and pandemic influenza vaccines and antimicrobial BDM-I for the treatment of serious human infections. BioDiem partners with other vaccine and infectious disease treatment companies through licensing its LAIV vaccine and other technologies. The LAIV is licensed to World Health Organisation as part of the Global Pandemic Influenza Action Plan. BioDiem is headquartered in South Melbourne, Victoria, Australia.
BioDiem Ltd Key Recent Developments
Mar 17,2017: BioDiem Announces its Half Year Results
Reasons to buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1-About the Company 5
BioDiem Ltd-Key Facts 5
BioDiem Ltd-Key Employees 6
BioDiem Ltd-Key Employee Biographies 7
BioDiem Ltd-Major Products and Services 8
BioDiem Ltd-History 9
BioDiem Ltd-Company Statement 11
BioDiem Ltd-Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2-Company Analysis 13
Company Overview 13
BioDiem Ltd-Business Description 14
BioDiem Ltd-Corporate Strategy 15
BioDiem Ltd-SWOT Analysis 16
SWOT Analysis-Overview 16
BioDiem Ltd-Strengths 16
BioDiem Ltd-Weaknesses 17
BioDiem Ltd-Opportunities 18
BioDiem Ltd-Threats 19
BioDiem Ltd-Key Competitors 20
Section 3-Company's Lifesciences Financial Deals and Alliances 21
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
BioDiem Ltd, Recent Deals Summary 23
Section 4-Company's Recent Developments 24
Mar 17, 2017: BioDiem Announces its Half Year Results 24
Section 5-Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List Of Figure
List of Figures
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 22
List Of Table
List of Tables
BioDiem Ltd, Key Facts 5
BioDiem Ltd, Key Employees 6
BioDiem Ltd, Key Employee Biographies 7
BioDiem Ltd, Major Products and Services 8
BioDiem Ltd, History 9
BioDiem Ltd, Subsidiaries 12
BioDiem Ltd, Key Competitors 20
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
BioDiem Ltd, Recent Deals Summary 23
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Products
BioDiem Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.
Companies
Therapix Biosciences Ltd
MedImmune LLC
Altimmune Inc
AdAlta Ltd